Maxime Le Merdy, Ph.D.

Director, PBPK Research & Collaborations
Simulations Plus, Inc.

Poster(s):

• (M0930-05-30) PBPK-Based Prediction of Obesity-Mediated Changes in Small Molecule Pharmacokinetics
  Monday, November 10, 2025

  9:30 AM - 10:30 AM CT

• (M1330-05-29) Predicting Aflibercept Local Exposure in Humans Using an Ocular PBPK Model
  Monday, November 10, 2025

  1:30 PM - 2:30 PM CT

• (T1330-09-60) Use of PBBM-PBPK to Predict Mesalamine Delayed-Release Oral Drug Products Performance in Both Healthy and Disease Physiologies
  Tuesday, November 11, 2025

  1:30 PM - 2:30 PM CT

• (M1430-05-30) From In Vitro Dissolution Testing to In Vivo Clinical Pharmacokinetic Prediction Using PBPK Models for Oral Cavity Drug Products
  Monday, November 10, 2025

  2:30 PM - 3:30 PM CT